Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- University of Colorado, Denver
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Measurement of L-arginine-NO biosynthesis pathways in the airway epithelium in obese and non-asthmatics.
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
The objective of this pilot study is to determine whether obesity and metabolic syndrome are in fact synergistic in relation to airway nitric oxide (NO) biology. To do so, the investigators want to determine how obesity and the metabolic syndrome relate to metabolism in bronchial airway epithelial cells and the nasal epithelium.
Detailed Description
This is a cross sectional pilot study comparing specific metabolic pathways in bronchial airway epithelial cells and the nasal epithelium across the following patient groups: 1. Obese (Body Mass Index (BMI) ≥ 30) asthmatics without metabolic syndrome, 2. Obese asthmatics with metabolic syndrome, 3. Obese non-asthmatics, and 4. Non - obese (lean \> 18 \<= 25, Overweight (OW) \> 25 - \<30) asthmatics. Participants in these groups will be matched by gender, age and asthma severity. To be enrolled, participants must be non-current smokers and be controlled. After meeting screening criteria, participants will undergo further evaluation to determine whether or not inclusion and exclusion criteria are met. Participants will undergo a baseline evaluation, lung function testing and a subsequent bronchoscopy and nasal epithelial brush sampling in those that meet study enrollment. Participants without a bronchodilator withhold will be scheduled to undergo a methacholine test. Those that qualify will undergo a bronchoscopy to obtain bronchoalveolar lavage and airway epithelial cells and nasal epithelial brush sampling for gene expression studies. After the procedure is done and post bronchoscopy safety standards are met, participants will be discharged from the inpatient Clinical Translational Research Center (CTRC) recovery area. The research coordinator will call the participant on the night of the procedure and on the next day to document post-procedure clinical stability.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For ALL Groups
- •Adequate completion of informed consent process with written documentation
- •Male and female patients, ≥ 18 - 65 years old
- •Smoking history \<10 pack years and no smoking in the last year
- •\*\*Subjects can be included in the study if they are on blood pressure treatment and are on a diet control/exercise only treatment of diabetes.
- •Specific to Asthma Groups
- •i. From all racial/ethnic backgrounds with a diagnosis of asthma based on physician diagnosis for \>6 months
- •Specific to Metabolic Syndrome Group. Metabolic syndrome diagnosis based on having at least any three of: a. Triglycerides ≥ 150 mg/dl; b. High-density lipoproteins (HDL) cholesterol ≤ 50 mg/dl for women and ≤ 40 mg/dl for men; c Fasting blood glucose ≥ 100 mg/dl; d. Waist circumference \> 40 inches males and \> 35 inches females); e. Previously diagnosed hypertension or on antihypertensive medication; f. Blood pressure greater than 130/85 on two consecutive measurements.
- •Specific to Non-Metabolic Syndrome Group a. Baseline pre-bronchodilator forced expiratory volume (FEV1) of 50% or greater of predicted with a 12% or greater bronchodilator (BD) response to 4 puffs of albuterol or PC20 methacholine (16 mg) if no BD response; b. BMI ≥ 30
- •Metabolic syndrome diagnosis based on having at least any three of:
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Measurement of L-arginine-NO biosynthesis pathways in the airway epithelium in obese and non-asthmatics.
Time Frame: Within 6 months of collection
L-arginine-NO biosynthesis pathways will be measured in the airway epithelium of mild to moderate controlled obese and non-obese asthmatics with metabolic syndrome by ELISA and western blot analysis.
Measurement of oxidative stress in the airway epithelium in obese and non-asthmatics.
Time Frame: Within 6 months of collection
Oxidative stress will be measured in the airway epithelium of mild to moderate controlled obese and non-obese asthmatics without metabolic syndrome by Griess Reaction and western blot analysis.
Secondary Outcomes
- Measurement of mitochondrial structural differences.(Within 6 months of collection)
- Measurement of mitochondrial density(Within 6 months of collection)
- Patterns of Gene expression found in the nasal epithelium.(Within 6 months of collection)